NDC 51688-9283 - A3266 NERVE BLOCK
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51688-9283
- Package NDCs from labels
- 51688-9283-2
- Manufacturer
- Smiths Medical ASD, Inc. | Hospira, Inc.
- Effective date
- 2016-07-18
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| A3266 NERVE BLOCK - Smiths Medical ASD, Inc. | Hospira, Inc. | Smiths Medical ASD, Inc. | Hospira, Inc. | 2016-07-18 | MEDICAL DEVICE |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LIDOCAINE HYDROCHLORIDE | ACTIVE INGREDIENT | V13007Z41A | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 | |
| LIDOCAINE | ACTIVE MOIETY | 98PI200987 | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 | |
| Hydrochloric Acid | INACTIVE INGREDIENT | QTT17582CB | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | A3266 NERVE BLOCK () KIT [SMITHS MEDICAL ASD, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ringers | SODIUM CHLORIDE, CALCIUM CHLORIDE, POTASSIUM CHLORIDE, | Baxter Healthcare Corporation | e1953d54-818d-46a6-8532-518ebae6d84e | 2012-06-13 | 451W47IQ8X | |
| Lactated Ringers | SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, CALCIUM CHLORIDE | Baxter Healthcare Corporation | f09f80bf-2f8b-4420-865d-aec2d5e5cd4d | 2012-06-12 | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.